Intermittent Vacuum Therapy (IVT) for Vascular Erectile Dysfunction (ED)

Target group: Men with vascular/arteriosclerotic erectile dysfunction (ED)
Method/Devices: IVT to the lower body: VACUMED® / VACUSPORT® / VACUSTYLER AVANTGARDE® [5][6][7]

Clinical Mechanism

• Alternating pressure (vacuum/atmospheric) → rhythmic vasodilation/compression, promoting macro- and microcirculation as well as venous and lymphatic return. [1]
• Endothelium/NO trigger: Vascular‑training programs explicitly indicate increased nitric‑oxide release (incl. in ED). [3][5][6]

Clinical Evidence

ED Indication in the Clinical Evaluation Report (CER)

“Vascular erectile dysfunction” is listed as an application of the VACUMED® technology. The CER provides a positive benefit assessment. [5][6] The vascular‑training program cites NO increase “including in erectile dysfunction.” [3]

Real‑World Evidence (RWE) & Practice Reports

An annual outcome report (Rio, 2020) from an Advanced Pain & Rehab center documents improvements in vascular outcomes (edema, walking distance, pain, sleep quality) in routine care; ED is listed as an indication. [5][6][7]

Practice reports repeatedly describe positive patient feedback after a series of sessions (e.g., less pain/edema, better load capacity/recovery). These are consistent with experiences reported by physiotherapy, medical, and rehab clinics. [3][7]

Interpretation

For ED primary endpoints (e.g., IIEF‑5), no prospective controlled trials are contained in the provided materials. The listed indication plus consistent microcirculatory/vascular rationale and RWE support an adjunctive use in vascular ED. [1][5][6][7][8]

Patient Selection

Suitable: Vascular/arteriosclerotic ED (risk profile of PAD, diabetes, hypertension, dyslipidemia, smoking). [1][5][6][7]

Less suitable: Primarily psychogenic, neurogenic, or endocrine ED without vascular involvement.

Therapy Protocol [3]

• Pressure range: Typically −20 to −70 mbar; vacuum and rest phases each configurable from 1–30 s; treatment time 25–45 min (commonly 25–30 min in practice). [3]
• Programs: Vascular training (P4–P6), PAD program (P3) — used as the base for vascular ED. [1][3][5][6]
• Initiation/escalation: Start low in the first session (~25 mbar); set intervals according to patient comfort (e.g., 10–15 s / 10–15 s); stop if not tolerated. [3]
• Series: 8–16 sessions over 3–6 weeks (inpatient possibly more frequent). [3]

Outcome Assessment (incl. Positive Patient Reports)

• Patient‑reported outcomes: IIEF‑5/SHIM (score 5–25; higher = better) before and after 8–12 sessions, optional follow‑up at 4–8 weeks; additionally collect patient feedback (rigidity, durability, spontaneous erections, satisfaction). [3][5][6][8]
• Objective measures (optional): Penile duplex‑Doppler (PSV/EDV), systemic surrogates (ABI, TcPO₂) — analogous to vascular/PAD indications in the materials. [1][5][6]
• RWE notes: Short practice questionnaire “Subjective change” after X sessions (e.g., +/0/− for rigidity/maintenance/spontaneous erection). [3][7]

Safety & Contraindications

• Do not use in: Acute thrombosis/thrombophlebitis (< 8 weeks), unstable angina pectoris, inguinal/abdominal wall hernia or indwelling catheter (e.g., PCD). [3]
• Post‑operative: Wait for sufficient wound healing; in severe hypertension only under supervision.
• Operating notes: Positioning, iris seal, emergency stop, hygiene (disinfectants listed by RKI/VAH). [3]

Summary

Rationale & practice: IVT → vascular training & microcirculation, NO trigger; ED is listed as an indication. Numerous positive patient reports after series treatments in physiotherapy/medical/rehab settings support real‑world feasibility (RWE). [1][3][5][6][7]

Evidence need: ED‑specific prospective trials with IIEF‑5 and penile duplex as primary endpoints are warranted. Until then, implement standardized outcome capture in your facility. [5][6][8]